WALD WALDENCAST ACQUISITION CORP

Waldencast plc Names Philippe Gautier Chief Financial Officer and Chief Operating Officer

Waldencast plc Names Philippe Gautier Chief Financial Officer and Chief Operating Officer

NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a global multi-brand beauty and wellness platform, today announced that Philippe Gautier will join the Company as Chief Financial Officer and Chief Operating Officer on October 19, 2022. In this role, Mr. Gautier will also serve as the principal financial officer of the Company.

Mr. Gautier comes to Waldencast following a successful, thirty-year career leading the finance and operations areas of prestigious global consumer companies. Most recently, Mr. Gautier served as Group Chief Financial Officer at Selecta – a KKR portfolio company. Prior to this, he spent five years as Group Chief Financial Officer and Operations, for SMCP (Sandro, Maje, Claudie Pierlot, De Fursac). In addition, for more than a decade, Mr. Gautier served as Chief Financial Officer of major brands at Kering, including Sergio Rossi and Puma, working in Italy and in the United States. Mr. Gautier began his career at HSBC asset management in Tokyo.

Michel Brousset, Waldencast’s Founder and CEO states, “We are pleased to attract Philippe to Waldencast and believe his vast financial and operational experience, business acumen and proven track record of delivering financial improvement and operational excellence while acquiring, integrating, nurturing, and developing global luxury consumer brands will be highly valuable to us as we position Waldencast to achieve its ambition to build out a world class portfolio of beauty and wellness brands.”

“I am thrilled to join Waldencast and bring my experience to elevate the solid foundation that has been created to advance the company’s ambition to build a global best-in-class beauty and wellness multi-brand platform,” said Mr. Gautier. “I look forward to working with the Waldencast team and contributing to the success of this incredible growth company for many years into the future.”

About Waldencast

Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth, purpose-driven brands.  Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the business combination with Obagi Skincare and Milk Makeup. As part of the Waldencast platform, brands will benefit from the operational scale of a multi-brand platform, expertise in managing global beauty brands at scale, a balanced portfolio to mitigate category fluctuations, asset-light efficiency and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: .

Contacts:

Investors

ICR

Allison Malkin/Annie Erner/Nina Weiss

Media

ICR

Brittney Fraser/Alecia Pulman



EN
27/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on WALDENCAST ACQUISITION CORP

 PRESS RELEASE

Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Vi...

Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness The clinically proven formula pairs NAD+ with its precursors to replenish skin cells and address nine signs of skin aging for healthier, more resilient-looking skin NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation, the originator of medical-grade skincare and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), is proud to announce the latest innovation in advanced skin science and...

 PRESS RELEASE

Waldencast Reports Q4 2025 and FY 2025 Financial Results

Waldencast Reports Q4 2025 and FY 2025 Financial Results FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 million Q4 2025 net revenue of $72.0 million, flat to Q4 2024 and Adjusted EBITDA of $6.6 million Obagi Medical sees continued revenue acceleration as a result of transformation efforts and continued brand momentum, alongside investments supporting the recent launch of its injectables platform Milk Makeup maintains U.S. consumption growth through distribution expansion, offset by softness in international markets Waldencast advanced its strategic ...

 PRESS RELEASE

Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings ...

Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date LONDON, March 11, 2026 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform announced that its Fourth Quarter and Fiscal Year 2025 earnings will be issued in a press release on March 13, 2026, prior to U.S. market open. The Company does not plan to host a conference call to discuss results given its ongoing strategic review. About Waldencast plc Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty...

 PRESS RELEASE

Obagi Medical and Schweiger Dermatology Announce Collaboration in the ...

Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ Schweiger selected as a leading dermatology platform partner due to its commitment to clinical excellence, rapid access to care, and dissemination across its extensive national network of practices NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced Schweiger Dermatology as a key...

 PRESS RELEASE

Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ...

Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ It’s a Secret Med Spa selected as a premier luxury med spa partner due to its commitment to excellence, personalized luxury aesthetic experiences, and outstanding patient results across its growing network of high-end locations NEW YORK and DALLAS, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch